Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets.

Vaccine - 17 Jan 2011

Yang PengHui, Duan YueQiang, Wang Cheng, Xing Li, Gao Xiao, Tang Chong, Luo DeYan, Zhao ZhongPeng, Jia Weihong, Peng Daxin, Liu Xiufan, Wang Xiliang

Abstract excerpt

A novel 2009 influenza A (H1N1) virus was transmitted from humans to humans worldwide. The live attenuated monovalent A H1N1 vaccine (LAMV) for intranasal administration has shown promising immunogenicity and safety in clinical trials and for human use, but the experimental data based on LAMV is incomplete. In this study, using reverse genetic technology, we produced a cold-adapted (ca), live attenuated BJ/AA ca...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferrets
Share to Immunity, Mucosal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunization, Secondary

Share to Influenza A Virus, H1N1 Subtype

Share to Influenza Vaccines

Share to Reassortant Viruses

Share to Respiratory Mucosa

Share to Vaccines, Attenuated

Source

Identifiers

PMID: 21111782
DOI: 10.1016/j.vaccine.2010.11.026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets.PMID 21111782Read ↗

A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.Semantic proximity Read ↗

Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets.Semantic proximity Read ↗

Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and FerretsSemantic proximity Read ↗

A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammalsSemantic proximity Read ↗

Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in FerretsSemantic proximity Read ↗

Evaluation of Live Attenuated Influenza A Virus H6 Vaccines in Mice and FerretsSemantic proximity Read ↗

Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman PrimatesSemantic proximity Read ↗

Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.Semantic proximity Read ↗

A single amino acid substitution in PB1 of pandemic H1N1 with A/Ann Arbor/6/60 master donor virus mutations as a novel live-attenuated influenza virus vaccineSemantic proximity Read ↗

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus ChallengeSemantic proximity Read ↗

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus ChallengeSemantic proximity Read ↗

Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.